HeartSciences (HSCS) Net Cash Flow Growth (1y) (2022 - 2026)
HeartSciences (HSCS) Net Cash Flow Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.88 Bn | 176.59 Bn | 6.27 Bn | -53.07% |
| 2 | Stryker | 128.94 Bn | 126.06 Bn | 3.81 Bn | 17.60% |
| 3 | Medtronic | 108.75 Bn | 99.53 Bn | 6.41 Bn | 10.50% |
| 4 | Boston Scientific | 68.65 Bn | 67.19 Bn | 3.61 Bn | -283.58% |
| 5 | Edwards Lifesciences | 48.22 Bn | 44.55 Bn | 1.29 Bn | -564.44% |
| 6 | Dexcom | 28.43 Bn | 27.31 Bn | 750.30 Mn | -31.84% |
| 7 | GE HealthCare Technologies | 28.32 Bn | 26.03 Bn | 1.98 Bn | -394.13% |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.10 Bn | 21.98 Bn | 2.07 Bn | 76.43% |
| 10 | HeartSciences | 6.62 Mn | 4.92 Mn | - | -16.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -16.14% |
| Oct 31, 2025 | -192.41% |
| Jul 31, 2025 | 215.41% |
| Apr 30, 2025 | -18.09% |
| Jan 31, 2025 | -120.86% |
| Oct 31, 2024 | 39.51% |
| Jul 31, 2024 | -35.31% |
| Apr 30, 2024 | -369.10% |
| Jan 31, 2024 | 709.28% |
| Oct 31, 2023 | 60.26% |
| Jul 31, 2023 | -132.34% |
| Apr 30, 2023 | 34.02% |
| Jan 31, 2023 | -219.54% |
| Oct 31, 2022 | -55.79% |
| Jul 31, 2022 | 567.50% |